NAVARA HEALTH
Functional · Hormonal · Aesthetic · Integrative
Membership Program Agreement

Hormone Optimization Program
Membership Information & Informed Consent

Bioidentical HRT · Women's & Men's Programs
Practice
Navara Health, PLLC
5301 Alpha Road, Suite 34, Room 21
Dallas, Texas 75240
Contact
469-653-3124
contact@navarahealthtx.com
Prescribing Provider
Jessica Boggs, MSN, APRN, FNP-C, ENP-C
Medical Director
Simal Patel, MD
Women's BHRT Telehealth States (Adults 18+)
Texas Colorado Connecticut Florida Iowa Oklahoma Vermont Virginia Washington
Men's TRT & Any Controlled Substance Prescribing
Texas Only · In-Person Required

Purpose of This Consent

This document provides education and consent for participation in Navara Health's Hormone Optimization Program, a monthly membership for evaluation, treatment, and ongoing monitoring of hormone-related symptoms in women and men. It addresses program structure, membership terms, financial obligations, monitoring requirements, expected benefits, risks, alternatives, and the practitioner-patient relationship.

Read the section that applies to you carefully. This document contains a common section that applies to all members, followed by sex-specific sections for the Women's BHRT Program and Men's HRT Program. Sign and initial each section that applies to your program enrollment.

Understanding Hormone Imbalance & Treatment Rationale

Hormone levels can change due to aging, perimenopause, menopause, andropause, chronic stress, thyroid dysfunction, adrenal imbalance, metabolic dysfunction, illness, pregnancy and postpartum changes, certain medications, or lifestyle factors. Hormone Optimization Therapy at Navara Health aims to support physiologic hormone balance through individualized treatment using bioidentical hormones, lifestyle guidance, and ongoing laboratory monitoring.

I understand that hormone optimization is:

Program Overview & Membership Tiers

Women's BHRT
Women's Hormone Optimization Membership
Starting at $275 / month

May include up to three (3) hormone prescriptions — for example: estradiol, progesterone, and/or low-dose testosterone — plus:

  • Home delivery of compounded medications
  • Follow-up labs at approximately 12 weeks, then quarterly
  • Virtual and/or in-person follow-up visits
  • Ongoing provider access for clinical questions
  • 10% discount on med spa services (excludes memberships)
Men's HRT
Men's Hormone Optimization Membership
Starting at $225 / month

May include testosterone therapy (injectable testosterone cypionate or enanthate up to 200 mg weekly, or compounded topical formulation), plus:

  • Injection supplies delivered to your home (if applicable)
  • Follow-up labs at approximately 12 weeks, then quarterly
  • Virtual and/or in-person follow-up visits
  • Direct provider access
  • 10% discount on med spa services (excludes memberships)

Optional Add-Ons (Either Program)

Additional HormoneDHEA, pregnenolone, oxytocin, low-dose naltrexone (LDN), etc.
+$25 / mo each
Thyroid OptimizationIncludes thyroid labs & medications (LT4, LT3, or compounded as clinically indicated)
+$100 / mo

I understand that medication type, dose, and route of administration are determined by my provider's clinical judgment based on labs, symptoms, response, and safety considerations, and may change over the course of therapy.

Membership Terms & Billing

I acknowledge and agree that:

What Is Not Included

Monitoring & Follow-Up Requirements

Hormone therapy requires ongoing monitoring for safety and effectiveness. I agree to:

Failure to comply with monitoring requirements may result in dose modification, suspension of refills, or discontinuation of therapy. Hormone prescriptions will not be refilled if required labs are overdue, incomplete, or significantly abnormal.

Potential Benefits (Not Guaranteed)

Individual responses vary, and no specific outcome is guaranteed. Potential benefits described in clinical literature may include:

General Risks Applicable to All Patients

Possible
General Risks & Considerations
Changes in blood pressure or lipid levels. Liver enzyme changes. Thyroid suppression or imbalance with thyroid optimization. Allergic reactions to medications or compounding base components. Need for ongoing dose adjustments. Injection-site reactions (with injectable formulations). Application-site reactions (with topical formulations). Effects of compounded medications (compounded preparations are not FDA-approved as finished drug products — see Section 7 and the separate Compounding Pharmacy Authorization).
Rare but Serious
Across All Hormone Therapy
Severe allergic reaction or anaphylaxis. Significant cardiovascular events (long-term cardiovascular risk profile varies by formulation, route, age, time since menopause, and individual factors). Unforeseen long-term effects — long-term safety data for hormone optimization in some populations is limited.

Sex-specific risks are addressed in the respective sections below.

Compounded Bioidentical Hormones

Many medications prescribed under this program are compounded preparations, including but not limited to compounded estradiol/progesterone capsules and topicals, low-dose testosterone for women, oxytocin, pregnenolone, and DHEA. I acknowledge that:

Women's BHRT Program · Sex-Specific Section

Common Symptoms Addressed

Medications & Routes

Women's BHRT may include one or more of the following, individualized to my clinical picture, menopausal status, and risk profile:

Off-Label Use Disclosure for Women. Use of testosterone in women is considered off-label in the United States; there is no FDA-approved testosterone product specifically for women. Use is supported by international clinical guidelines (Global Consensus Position Statement on the Use of Testosterone Therapy for Women) and is at the provider's clinical discretion based on symptoms and labs.

Women's HRT Risks

Common
Generally Mild & Manageable
Breast tenderness or fullness. Spotting or menstrual changes. Fluid retention or bloating. Mood changes (often related to dose or balance). Headaches. Nausea (with oral estrogen). Injection-site reactions (with testosterone injection). Application-site irritation (with topical formulations).
Possible
With Androgen Therapy (Testosterone)
Acne or oily skin. Mild facial or body hair growth (hirsutism). Voice deepening (usually only with supraphysiologic dosing — Navara aims to maintain physiologic ranges). Clitoral sensitivity changes. Mood changes. Lipid changes. Elevated red blood cell count is uncommon at female-physiologic doses but is monitored.
Rare but Serious
Women's HRT
Increased clotting risk (venous thromboembolism, stroke) — particularly with oral estrogen; transdermal estrogen carries a lower clotting risk profile. Breast cancer risk discussion — long-term combined estrogen + progestin therapy may modestly increase breast cancer risk in some populations; risk depends on formulation, duration, age at initiation, and personal/family history. Endometrial hyperplasia or carcinoma — risk in women with a uterus receiving unopposed estrogen; progesterone is co-prescribed to mitigate. Cardiovascular events — risk profile depends on timing of initiation relative to menopause, route, and individual factors. Gallbladder disease (oral estrogen). Severe allergic reaction.

Women's HRT Contraindications & Cautions

Women's Lab Monitoring

Recommended labs may include, but are not limited to:

I agree to ongoing age-appropriate breast and gynecologic screening with my primary care provider or gynecologist, including mammograms and pelvic exams.

Men's HRT Program · Sex-Specific Section

Critical Controlled Substance Notice. Testosterone is a DEA Schedule III controlled substance. Men's testosterone therapy at Navara Health requires an in-person evaluation in Texas and signature of the separate Testosterone Therapy Controlled Substance Agreement. Men's TRT is not available via telehealth to patients outside Texas, regardless of multi-state licensing. The Controlled Substance Agreement is incorporated by reference and contains additional requirements regarding lab monitoring, PMP compliance, prescription security, drug screening, and termination grounds.

Common Symptoms Addressed

Medications & Routes

Clinical Philosophy. Navara Health prescribes testosterone to maintain physiologic ranges (typically targeting mid-to-upper normal range for the patient's age). Supraphysiologic dosing is not provided. Aromatase inhibitors are not routinely prescribed; estradiol in men is managed primarily through dose and frequency optimization, with aromatase inhibition reserved for symptomatic patients with significantly elevated estradiol after dose optimization has been attempted.

Men's HRT Risks

Common
Generally Manageable
Acne or oily skin. Mood irritability (often related to peak/trough dosing — addressed by dose frequency optimization). Increased libido or aggression. Injection-site reactions or soreness. Application-site irritation (with topical). Mild fluid retention.
Possible
Requires Monitoring
Erythrocytosis / polycythemia (elevated red blood cell count and hematocrit) — monitored every 3 months; may require dose reduction, phlebotomy, or therapeutic blood donation. Testicular shrinkage and reduced fertility — testosterone therapy suppresses endogenous testosterone production and spermatogenesis; HCG or enclomiphene may be considered for men wishing to preserve fertility. Gynecomastia (breast tissue development). Worsening of obstructive sleep apnea. Mild prostate enlargement (BPH symptoms). Edema. Hair loss acceleration in genetically predisposed men. Mood changes including irritability or depression. Lipid changes.
Rare but Serious
Men's TRT
Severe erythrocytosis with thrombotic risk (heart attack, stroke, deep vein thrombosis). Cardiovascular events — the long-term cardiovascular risk profile of TRT remains an area of ongoing research; recent large trials (TRAVERSE) have not shown increased cardiac events in well-monitored therapy, but individual risk varies. Prostate cancer detection / progression considerations — TRT does not cause prostate cancer per current evidence, but it may unmask occult cancer; PSA monitoring is required. Severe sleep apnea. Significant gynecomastia requiring intervention. Severe allergic reaction.

Men's TRT Contraindications & Cautions

Men's Lab Monitoring

Required baseline and follow-up labs include, but are not limited to:

Lab cadence: baseline, quarterly during titration, yearly once optimized. More frequent monitoring may be reinstated if labs become abnormal or new symptoms develop.

Fertility Disclosure

I understand that exogenous testosterone suppresses sperm production and can cause infertility, which may be reversible after discontinuation but is not guaranteed to return to baseline. If I wish to preserve fertility now or in the future, I will discuss adjunctive HCG, enclomiphene, or sperm banking with my provider before starting therapy.

Alternatives to Hormone Optimization

Alternatives may include, but are not limited to:

I may decline or discontinue hormone therapy at any time, subject to the membership cancellation terms in Section 3.

Communication & HIPAA Authorization

I authorize Navara Health to communicate with me regarding scheduling, prescription management, lab results, monitoring, billing, and follow-up through:

I understand that email and SMS are not fully secure channels. I may revoke authorization for any specific channel in writing to contact@navarahealthtx.com, except where required for legally mandated notices.

Financial Policy & No-Refund Agreement

Termination of the Membership

Navara Health reserves the right to terminate the membership and practitioner-patient relationship with written notice for:

Where required by law, the practice will provide written notice and a reasonable continuity-of-care period (typically 30 days) for the patient to establish care elsewhere, except where immediate termination is warranted by safety concerns.

Assumption of Risk & Release of Liability

I voluntarily assume all known, unknown, and unforeseen risks associated with hormone optimization therapy. To the fullest extent permitted by law, I agree to release, indemnify, and hold harmless Navara Health, PLLC, Jessica Boggs APRN, the medical director, and all affiliated providers, nurses, staff, contractors, and agents from liability for:

This release does not apply to cases of gross negligence or willful misconduct, and does not waive any right that cannot lawfully be waived under the laws of my state of residence.

Dispute Resolution & Binding Arbitration

Any dispute, controversy, or claim arising out of or relating to this Consent, the Hormone Optimization Program, prescription of hormones, or the practitioner-patient relationship — including any claim of medical malpractice, billing dispute, or breach of contract — shall first be addressed by good-faith negotiation between the parties.

If the matter cannot be resolved through negotiation within thirty (30) days, the parties agree to submit the dispute to binding arbitration administered by a recognized arbitration body (such as the American Arbitration Association) under its applicable rules, with the arbitration to take place in Dallas County, Texas, unless otherwise required by the laws of the patient's state of residence.

The parties acknowledge that by agreeing to arbitration, they are waiving the right to a jury trial. This provision does not waive any right that cannot lawfully be waived under the patient's state law. Either party retains the right to seek injunctive or equitable relief in court where appropriate.

Governing Law & Severability

This Consent shall be governed by and construed under the laws of the State of Texas, except where the laws of the patient's state of residence require otherwise. If any provision is found unenforceable, the remaining provisions shall remain in full force and effect.

Emergency Disclaimer

Navara Health Does Not Provide Emergency Care

Call 911 or go to the nearest emergency room for:

For mental health crises, call or text 988 (Suicide & Crisis Lifeline).

Program Selection — Required

Please initial the program(s) I am enrolling in today. I acknowledge that I have read and agree to the sex-specific section that applies to my enrolled program.

Women's BHRT Program I am enrolling in the Women's BHRT Membership and have read the Women's-specific section above. I understand the medications, routes, risks, contraindications, monitoring requirements, and off-label disclosure for women's testosterone.
Men's HRT Program I am enrolling in the Men's HRT Membership and have read the Men's-specific section above. I understand that testosterone is a DEA Schedule III controlled substance, that men's TRT is restricted to Texas in-person evaluation, and that I will sign the separate Testosterone Therapy Controlled Substance Agreement as a condition of starting therapy.
Optional Add-Ons Selected I am selecting one or more optional add-ons: ☐ Additional hormone(s) at +$25/month each (specify: __________________________)   ☐ Thyroid Optimization at +$100/month

Patient Initials — Required for Each Critical Clause

Each of the following requires my separate written initials.
I understand this is a recurring monthly membership with auto-pay, a 3-month minimum commitment, and 7 days' written notice required to cancel after the initial commitment.
Initials
I understand that membership fees are non-refundable, regardless of outcomes, response, or my decision to discontinue therapy.
Initials
I understand that required lab monitoring at 12 weeks and quarterly thereafter is a condition of continued therapy, and that refills will not be issued if labs are overdue or significantly abnormal.
Initials
I understand that compounded bioidentical hormones are not FDA-approved as finished drug products, and that a separate Compounding Pharmacy Authorization applies.
Initials
Women only: I understand the off-label use of testosterone in women, the increased clotting risk associated with oral (vs. transdermal) estrogen, and that pellets are not used at Navara Health.
Initials (if applicable)
Men only: I understand that testosterone is a DEA Schedule III controlled substance, that men's TRT requires an in-person Texas evaluation, that the separate Testosterone Therapy Controlled Substance Agreement must be signed, and the fertility suppression risk associated with exogenous testosterone.
Initials (if applicable)
I agree to binding arbitration as described in Section 13 and understand that I am waiving the right to a jury trial.
Initials

Acknowledgment & Electronic Consent

By signing below (or by typing my full legal name as an electronic signature), I confirm and agree:

Patient Printed Name
Date of Birth
State of Residence at Time of Signing
Program Enrolled (Women's BHRT / Men's HRT)
Patient Signature (or Typed Electronic Signature)
Date
Provider Signature — Jessica Boggs, APRN, FNP-C, ENP-C
Date